Fundsmith Reduces $43M in Exponent, Inc. ($EXPO)

Fundsmith sold all its shares in Exponent, Inc., marking a complete exit from the position.

Written by Trueearnings · Published Jun 14, 2026, 4:53 AM EDT

Key Points

Fundsmith sold all 746,820 shares in Exponent, Inc. (EXPO) according to its latest 13F filing, completely exiting its position.
Exponent, Inc. (EXPO) trades around $57.08, with a market cap of approximately $2.77 billion and a P/E ratio of 26.67.
Insiders at Exponent, Inc. have been active, with several buying and one selling shares recently; analysts maintain mixed ratings with a target mean price of $81.67.

Fundsmith has completely sold its position in Exponent, Inc. (NasdaqGS: EXPO), according to its latest 13F filing with the SEC. The fund sold all 746,820 shares it previously held, marking a 100% reduction in its holdings. This change was reported as of the end of the filing period.

What Changed in Fundsmith's Exponent Position

Fundsmith had held 746,820 shares of Exponent, Inc. but decided to sell all of them, resulting in a 100% decrease in its stake. The shares were valued at the time of sale, but the exact value was not disclosed in the filing.

Other Institutional Activity in Exponent

Other major funds also adjusted their positions in Exponent, Inc. BlackRock, Inc. trimmed its holdings by 95,655 shares, ending with about 6,068,812 shares valued at approximately $396 million. Kayne Anderson Rudnick Investment Management LLC reduced its stake by 256,799 shares, holding 3,886,308 shares worth about $254 million. On the other hand, Vanguard Portfolio Management LLC increased its position by 2,946,756 shares, bringing its total to the same number of shares, valued at around $192 million. Conestoga Capital Advisors, LLC notably cut its holdings by 485,994 shares, resulting in a total of 1,906,505 shares valued at about $124 million.

Exponent, Inc. Stock Snapshot

Shares of Exponent, Inc. (NasdaqGS: EXPO) are trading near $57.08. The company has a market capitalization of roughly $2.77 billion and a P/E ratio of 26.67, with a forward P/E of 20.68. Its beta is 0.73, reflecting lower volatility compared to the market. The stock's 52-week range is between $51.91 and $81.95. The company's 50-day moving average is $62.07, while the 200-day moving average is $68.44.

Recent Earnings

Exponent, Inc. reported revenue of approximately $551.1 million, with a revenue growth rate of 10.5%. The company's net margin stands at 19.76%, and it has a return on equity of 27.94%. The next earnings report is expected on July 30, 2026.

Dividend

Exponent, Inc. pays an annual dividend rate of $1.22, yielding 2.14% with a dividend payout ratio of 56.54%.

Insider Buying and Selling at Exponent, Inc.

Recent insider activity at Exponent, Inc. included several purchases. On June 4, 2026, insiders such as Debra Zumwalt, George Brown, Carol Lindstrom, and Karen Richardson each bought 2,859 shares. Additionally, on June 3, 2026, George Brown purchased 2,009 shares, while Paul Johnston sold 2,009 shares.

Analysts Set New Price Targets

On May 15, 2026, JP Morgan maintained a buy rating for Exponent, Inc. with a price target of $80. UBS maintained its hold rating with a target of $75 on May 1, 2026. The consensus among analysts is a target mean price of $81.67, based on three analyst opinions.

About Exponent, Inc.

Exponent, Inc. is a consulting firm based in Menlo Park, California, specializing in science and engineering. The company serves various sectors, including chemicals, construction, consumer products, energy, and more. It operates through two segments: Engineering and Other Scientific, and Environmental and Health. Dr. Catherine Ford Corrigan leads the company as CEO, with a workforce of over 1,000 employees.

Bottom Line

Fundsmith's complete exit from Exponent, Inc. reflects a significant shift in its portfolio strategy. Investors often track such moves to gauge institutional sentiment. It's important to remember that 13F filings are backward-looking and may not represent current positions.